Thus, our findings may have significant clinical implications, not only for the treatment of sepsis, but also for other analogous inflammation-driven conditions, such as cancer and malaria, where NOS/•NO deregulation, and consequent loss of control over key inflammatory mediators, are equally pathogenic [115, 116]. This evidence concerns the gene NOS1 and Sepsis.